UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007232
Receipt number R000008520
Scientific Title A randomized clinical trial to evaluate the preventive effect of cranberry juice (UR65) for patients with recurrent urinary tract infection
Date of disclosure of the study information 2012/02/06
Last modified on 2012/02/06 16:34:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized clinical trial to evaluate the preventive effect of cranberry juice (UR65) for patients with recurrent urinary tract infection

Acronym

The preventive effect of cranberry juice for patients with recurrent UTI

Scientific Title

A randomized clinical trial to evaluate the preventive effect of cranberry juice (UR65) for patients with recurrent urinary tract infection

Scientific Title:Acronym

The preventive effect of cranberry juice for patients with recurrent UTI

Region

Japan


Condition

Condition

Urinary tract infection

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the recurrent rate in a randomized clinical trial for the patients with recurrent urinary tract infection with cranberry juice(UR65)or placebo

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Recurrent rate of urinary tract infection

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

The subjects receive cranberry juice(UR65;125ml)once a day for 24weeks.

Interventions/Control_2

The subjects receive placebo beverage once a day for 24weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

79 years-old >=

Gender

Male and Female

Key inclusion criteria

The patients with recurrent urinary tract infection including the patients with treatment completely,age from 20 to 79 year-old,outpatient clinic

Key exclusion criteria

The patients with urinary catheter indwelling,concomitant urethritis,prostatitis or epididymitis,urinary tract stone disease,urinary tract malignant disease,urinary obstruction,systemic severe condetion or other complications

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tetsuro Matsumoto

Organization

University of Occupational and Environmental Healht

Division name

Department of Urology

Zip code


Address

1-1,Iseigaoka,Yahata-nish-ku,kitakyushu,fukuoka,807-8555 Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Ryoichi Hamasuna

Organization

NPO"CREC net"

Division name

Secretariat

Zip code


Address

3-8-1,hananoji,wakamatuku,kitakyushu,fukuoka,808-0136 Japan

TEL

(093)741-5887

Homepage URL


Email



Sponsor or person

Institute

Workshop of urinary tract infection

Institute

Department

Personal name



Funding Source

Organization

NISSIN Science incorporated company

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)

KIKKOMAN CORPORATION


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

西野クリニック(岐阜県)、石山泌尿器科皮膚科(岐阜県)、岐阜泌尿器科(岐阜県)、土井クリニック(岐阜県)、彦坂病院(兵庫県)、中野泌尿器科(兵庫県)、細部医院(東京都)、福山泌尿器科病院(福岡県)、かじクリニック(福岡県)、加野病院(福岡県)、黒住泌尿器科医院(福岡県)、高山病院(福岡県)、西南泌尿器科クリニック(福岡県)、泌尿器科・皮フ科かわの医院(福岡県)泌尿器科いとうクリニック(福岡県)、山元泌尿器科医院(福岡県)、かわい泌尿器科クリニック(福岡県)、山口皮フ泌尿器科医院(福岡県)


Other administrative information

Date of disclosure of the study information

2012 Year 02 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 09 Month 03 Day

Date of IRB


Anticipated trial start date

2007 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 02 Month 06 Day

Last modified on

2012 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008520


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name